Anti-Trafficking Statement

Omnicell, Inc. Modern Slavery Act Group Statement for the Financial Year ending 2020



Introduction

Omnicell, Inc. makes this statement relating to modern slavery and human trafficking on behalf of the Omnicell Group of companies. In doing so, Omnicell, Inc. acknowledges its obligations under relevant global anti-slavery legislation including the California Transparency in Supply Chains Act 2010 and the UK’s Modern Slavery Act 2015 (“anti-slavery legislation”). We refer to the Omnicell Group of companies in this statement as “Omnicell”.

At Omnicell, we take the position that we are accountable not only to our customers and shareholders, but also to our global community.

As part of our drive to ensure that all aspects of our business are built on strong foundations of fairness, ethical behavior and integrity, Omnicell is committed to combatting the risk of modern slavery and human trafficking in its business and supply chain.

Although not all Omnicell group companies are required to comply with anti-slavery legislation, we have determined to adopt a Group wide approach to matters of human rights and corporate social responsibility. Accordingly, while this statement is published on behalf of all Omnicell Group companies who are specifically required by anti-slavery legislation to publish an annual modern slavery statement, it applies to the Group as a whole.



Our Business

Omnicell is a leading provider of solutions targeting patient safety and operational efficiency in healthcare facilities. Omnicell is a leader in the drive to deliver autonomous pharmacy services across the world.

Omnicell is headquartered in California, USA and has seven offices in the USA. It also has offices in China, France, Germany, Italy, the Netherlands, UAE and the United Kingdom.

Details of the Omnicell Group and the countries it operates in are available in the Omnicell, Inc. Annual Report and on the Omnicell, Inc. website.



Omnicell's Policy

Omnicell regularly updates its corporate policies, both internal and external, in the light of changes to relevant legislation and regulation in the countries it operates.

Omnicell does not tolerate modern slavery and human trafficking in its workplace and its internal policies and staff engagement publically support that stance. Omnicell does not knowingly associate with third parties who tolerate modern slavery and human trafficking in their businesses and supply chains. Omnicell’s policies and standard supply contracts reflect this stance.

As part of our commitment to integrity in all aspects of our business, Omnicell strives to be fully compliant with all applicable legislation and regulations including those with respect to modern slavery. As an example, Omnicell is committed to complying with the Dodd-Frank Wall Street Reform and Consumer Protection Act regarding the use of so-called “conflict minerals” such as tin, tantalum, tungsten, and gold in the solutions we build. We are committed to taking reasonable measures to source conflict-free minerals, and encourage our suppliers and partners to do the same.

Omnicell also holds SEDEX membership ID number ZC1001136, in this regard which clarifies Omnicell’s current policy.

Omnicell follows the 5-step process recommended by the internationally recognized OECD Due Diligence Guidance for Responsible Supply Chains of Minerals from Conflict-Affected and High-Risk Areas.



Omnicell's Supply Chain

Omnicell procures a variety of products and services from suppliers around the world. Given the nature and geography of Omnicell's business, its supply chain is both extensive and diverse. Many of its suppliers have their own extensive supply chains and we require our immediate suppliers to adopt ethical and compliance driven practices not only in their own businesses, but also in their supply chains. Omnicell will verify on an annual basis the steps its suppliers take to combat human trafficking and slavery.

Omnicell has zero tolerance for human trafficking and slavery and has adopted measures, such as including terms in its contracts with suppliers, to ensure that Omnicell employees, agents and suppliers do not engage in human trafficking and slavery activities and it will regularly revise those measures to keep in step with relevant legislation such as the relevant Act. 



Supply Chain Assessment and Audits

As part of Omnicell’s standard supplier contracts there are specific clauses linked to modern slavery and human trafficking. Where our contracts address the supply of products to our Californian companies we have introduced specific provisions to require our suppliers to certify that materials incorporated into the products comply with the laws regarding slavery and human trafficking of the country or countries in which they are doing business. 

As a part of our product verification and assurance process, our product supply contracts also reserve the right for Omnicell to conduct audits, both by ourselves and through independent third-party auditors, to assure ourselves of the supplier’s compliance with all aspects of the supply contract.

In addition, there are regular internal supply chain audits / assessments to verify the quality, environmental legal compliance, health and safety practices of our suppliers to ensure conformity with these requirements.



Internal Accountability

Omnicell has updated its internal employee induction process which includes training on Omnicell’s ethical stance in conducting its business. Our annual compliance training includes modules on human trafficking and slavery, particularly with respect to mitigating risks within the supply chains of products.

An integrity and compliance hotline is open at all times to all Omnicell employees, customers, suppliers and other individuals to alert the Omnicell Compliance Team on an anonymous basis.

Omnicell takes compliance with its ethical requirements seriously and failure to follow company policy will result in disciplinary action which may include termination of employment. For our suppliers, failure to comply with the terms of the supply contracts may lead to termination of those contracts.

This Group statement has been approved by the Board of Directors of Omnicell, Inc.

omnicell closing icon